調查批次:CHT2014-04 | 檢體寄出日期:2014-04-21 | 報告回收截止日期:2014-04-28 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
1.08 |
-0.12 |
-10.0 |
-1.2 |
-0.6 |
-40 |
2.59 |
-0.35 |
-11.9 |
-1.5 |
-0.5 |
-49 |
RH07b | RH07 | 2 |
2 |
3 |
1.31 |
0.11 |
9.2 |
1.1 |
0.7 |
37 |
4.70 |
1.76 |
59.9 |
7.3 |
1.4 |
244 |
RH14 | RH14 | 7 |
2 |
3 |
1.29 |
0.09 |
7.5 |
0.9 |
0.6 |
30 |
4.00 |
1.06 |
36.1 |
4.4 |
0.8 |
147 |
RH15 | RH15 | 4 |
2 |
5 |
1.31 |
0.11 |
9.2 |
1.1 |
0.7 |
37 |
2.48 |
-0.46 |
-15.6 |
-1.9 |
-0.6 |
-64 |
CL009 | CL009 | 2 |
2 |
5 |
1.09 |
-0.11 |
-9.2 |
-1.1 |
-0.6 |
-37 |
2.34 |
-0.60 |
-20.4 |
-2.5 |
-0.8 |
-83 |
CL010 | CL010 | 1 |
2 |
6 |
0.84 |
-0.36 |
-30.0 |
-3.6 |
-1.9 |
-120 |
2.80 |
-0.14 |
-4.8 |
-0.6 |
-0.3 |
-19 |
CL012 | CL012 | 7 |
2 |
3 |
1.43 |
0.23 |
19.2 |
2.3 |
1.3 |
77 |
4.53 |
1.59 |
54.1 |
6.6 |
1.3 |
221 |
CL013 | CL013 | 3 |
2 |
5 |
1.11 |
-0.09 |
-7.5 |
-0.9 |
-0.4 |
-30 |
2.46 |
-0.48 |
-16.3 |
-2.0 |
-0.6 |
-67 |
CL015 | CL015 | 2 |
2 |
4 |
1.19 |
-0.01 |
-0.8 |
-0.1 |
0.0 |
-3 |
2.58 |
-0.36 |
-12.2 |
-1.5 |
-0.5 |
-50 |
Median of RIA Group |
1.19 |
2.59 |
||||||||||||||
Range of RIA Group |
0.84 - 1.43 |
2.34 - 4.70 |
||||||||||||||
Robust mean of RIA Group |
1.19 ( n = 9 ) |
3.16 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.18 |
1.09 |
||||||||||||||
CV of RIA Group |
15.1% |
34.5% |
||||||||||||||
Median of European RIA Labs |
1.21 ( n = 101 ) |
2.79 ( n = 100 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.07 - 1.41 |
2.64 - 3.01 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
4 |
9 |
1.30 |
0.10 |
8.3 |
1.0 |
1.2 |
33 |
3.20 |
0.26 |
8.8 |
1.1 |
0.8 |
36 |
RH02c | RH02 | 2 |
4 |
1 |
0.95 |
-0.25 |
-20.8 |
-2.5 |
-1.1 |
-83 |
2.03 |
-0.91 |
-31.0 |
-3.8 |
-3.9 |
-126 |
RH06 | RH06 | 1 |
4 |
9 |
1.35 |
0.15 |
12.5 |
1.5 |
1.5 |
50 |
3.36 |
0.42 |
14.3 |
1.8 |
1.4 |
58 |
RH07a | RH07 | 1 |
4 |
2 |
0.98 |
-0.22 |
-18.3 |
-2.2 |
-0.9 |
-73 |
2.97 |
0.03 |
1.0 |
0.1 |
-0.2 |
4 |
RH12 | RH12 | 2 |
4 |
2 |
1.11 |
-0.09 |
-7.5 |
-0.9 |
-0.1 |
-30 |
3.14 |
0.20 |
6.8 |
0.8 |
0.5 |
28 |
RH19 | RH19 | 1 |
4 |
2 |
1.04 |
-0.16 |
-13.3 |
-1.6 |
-0.5 |
-53 |
3.05 |
0.11 |
3.7 |
0.5 |
0.2 |
15 |
RH20 | RH20 | 4 |
4 |
7 |
1.10 |
-0.10 |
-8.3 |
-1.0 |
-0.1 |
-33 |
3.00 |
0.06 |
2.0 |
0.3 |
-0.0 |
8 |
CL005 | CL005 | 1 |
4 |
9 |
1.27 |
0.07 |
5.8 |
0.7 |
1.0 |
23 |
3.19 |
0.25 |
8.5 |
1.0 |
0.7 |
35 |
CL006a | CL006 | 1 |
4 |
7 |
1.08 |
-0.12 |
-10.0 |
-1.2 |
-0.3 |
-40 |
2.99 |
0.05 |
1.7 |
0.2 |
-0.1 |
7 |
CL008 | CL008 | 3 |
4 |
2 |
1.01 |
-0.19 |
-15.8 |
-1.9 |
-0.7 |
-63 |
2.84 |
-0.10 |
-3.4 |
-0.4 |
-0.7 |
-14 |
CL011 | CL011 | 1 |
4 |
13 |
1.20 |
0.00 |
0.0 |
0.0 |
0.5 |
0 |
3.10 |
0.16 |
5.4 |
0.7 |
0.4 |
22 |
CL014b | CL014 | 2 |
4 |
1 |
1.00 |
-0.20 |
-16.7 |
-2.0 |
-0.8 |
-67 |
2.17 |
-0.77 |
-26.2 |
-3.2 |
-3.4 |
-107 |
Median of CLIA Group |
1.09 |
3.03 |
||||||||||||||
Range of CLIA Group |
0.95 - 1.35 |
2.03 - 3.36 |
||||||||||||||
Robust mean of CLIA Group |
1.12 ( n = 12 ) |
3.01 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.15 |
0.25 |
||||||||||||||
CV of CLIA Group |
13.4% |
8.3% |
||||||||||||||
Median of European CLIA Labs |
1.20 ( n = 1007 ) |
2.97 ( n = 962 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.00 - 1.29 |
2.70 - 3.21 |
||||||||||||||
Median of All Labs |
1.11 |
2.99 |
||||||||||||||
Range of All Labs |
0.84 - 1.43 |
2.03 - 4.70 |
||||||||||||||
Robust mean of All Labs |
1.15 ( n = 21 ) |
2.94 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.16 |
0.56 |
||||||||||||||
CV of All Labs |
13.9% |
19.0%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.20 |
2.94 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.00 - 1.31 |
2.59 - 3.22 |
||||||||||||||
Mean of All European Labs |
1.17 ( n = 1171 ) |
2.88 ( n = 1137 ) |
||||||||||||||
SD of All European Labs |
0.16 |
0.45 |
||||||||||||||
CV of All European Labs |
13.5% |
15.5% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.10 |
0.24 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, |
Diasorin |
4 |
CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL013, |
MP |
6 |
CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2014-05-01